Jean Duvall
Direttore/Membro del Consiglio presso ONDINE BIOMEDICAL INC.
Patrimonio netto: 13 994 $ in data 30/04/2024
Posizioni attive di Jean Duvall
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONDINE BIOMEDICAL INC. | Direttore/Membro del Consiglio | 07/12/2021 | - |
Independent Dir/Board Member | 07/12/2021 | - | |
ROQUEFORT THERAPEUTICS PLC | Direttore/Membro del Consiglio | 05/04/2022 | - |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Direttore/Membro del Consiglio | - | - |
Consigliere Generale | 01/11/2006 | - | |
Segretario Aziendale | 01/11/2006 | - | |
Repronovo SA | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Fondatore | - | - |
Storia della carriera di Jean Duvall
Precedenti posizioni note di Jean Duvall
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ferring Research Ltd. | Direttore/Membro del Consiglio | - | - |
International School of Lausanne | Direttore/Membro del Consiglio | - | - |
Ferring Properties SA | Direttore/Membro del Consiglio | - | - |
Gliotherapy Ltd. | Direttore/Membro del Consiglio | - | - |
Kuopio Center For Gene & Cell Therapy Kct oy | Direttore/Membro del Consiglio | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░ ░░░ | ░░░░░░░ ░░░░░░░ | - | - |
Formazione di Jean Duvall
Case Western Reserve University | Undergraduate Degree |
The Ohio State University | Graduate Degree |
Statistiche
Distribuzione geografica
Svizzera | 7 |
Regno Unito | 7 |
Stati Uniti | 5 |
Posizioni
Director/Board Member | 18 |
Founder | 3 |
General Counsel | 2 |
Settori
Health Technology | 11 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ONDINE BIOMEDICAL INC. | Health Technology |
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Aziende private | 18 |
---|---|
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Repronovo SA | |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Health Technology |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company is based in Middlesex, UK and was founded in 1980. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
Trizell Holding SA | |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
CPSI Holdings Ltd. | |
CPSI Scotland Ltd.
CPSI Scotland Ltd. Financial ConglomeratesFinance Part of CPSI Holdings Ltd., CPSI Scotland Ltd. is a financial services provider. The company is based in East Kilbride, UK. CPSI Scotland was founded in 2011. | Finance |
Ferring Pharmaceuticals SA
Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
Amzell BV | |
Gliotherapy Ltd. | |
Kuopio Center For Gene & Cell Therapy Kct oy | |
International School of Lausanne | |
Ferring Properties SA | |
Ferring Research Ltd. |
- Borsa valori
- Insiders
- Jean Duvall
- Esperienza